- Home
- SOND vs CARA Comparison
SOND vs CARA Comparison
Compare SOND & CARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOND
- CARA
- Stock Information
- Founded
- SOND 2014
- CARA 2004
- Country
- SOND United States
- CARA United States
- Employees
- SOND N/A
- CARA N/A
- Industry
- SOND Hotels/Resorts
- CARA Biotechnology: Pharmaceutical Preparations
- Sector
- SOND Consumer Discretionary
- CARA Health Care
- Exchange
- SOND Nasdaq
- CARA Nasdaq
- Market Cap
- SOND 26.5M
- CARA 23.6M
- IPO Year
- SOND N/A
- CARA 2014
- Fundamental
- Price
- SOND $1.98
- CARA $4.94
- Analyst Decision
- SOND
- CARA Hold
- Analyst Count
- SOND 0
- CARA 3
- Target Price
- SOND N/A
- CARA $12.00
- AVG Volume (30 Days)
- SOND 22.1K
- CARA 10.4K
- Earning Date
- SOND 04-08-2025
- CARA 05-12-2025
- Dividend Yield
- SOND N/A
- CARA N/A
- EPS Growth
- SOND N/A
- CARA N/A
- EPS
- SOND N/A
- CARA N/A
- Revenue
- SOND $624,458,000.00
- CARA $7,137,000.00
- Revenue This Year
- SOND $28.50
- CARA N/A
- Revenue Next Year
- SOND $17.62
- CARA N/A
- P/E Ratio
- SOND N/A
- CARA N/A
- Revenue Growth
- SOND 8.32
- CARA N/A
- 52 Week Low
- SOND $0.88
- CARA $2.71
- 52 Week High
- SOND $10.50
- CARA $11.39
- Technical
- Relative Strength Index (RSI)
- SOND 30.90
- CARA 44.62
- Support Level
- SOND $2.00
- CARA $5.30
- Resistance Level
- SOND $2.45
- CARA $5.74
- Average True Range (ATR)
- SOND 0.18
- CARA 0.27
- MACD
- SOND -0.00
- CARA -0.03
- Stochastic Oscillator
- SOND 1.66
- CARA 7.49
About SOND Sonder Holdings Inc.
Sonder Holdings Inc is engaged in providing short and long-term accommodations to travelers in various cities across North America, Europe, and the Middle East. The Sonder units in each apartment-style building and each hotel property are selected, designed, and managed directly by the Company. The Company generates revenues by providing short-term or month-to-month accommodations to its guests. The Company also provides accommodations to travelers through boutique hotels.
About CARA Cara Therapeutics Inc.
Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.